Reviva Pharmaceuticals (RVPH) Earnings Date, Estimates & Call Transcripts → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free RVPH Stock Alerts $1.37 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 12EstimatedActual EPS (May. 14) -$0.25 Beat By $0.03 Consensus EPS (May. 14) -$0.28 Get Reviva Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for RVPH and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRVPH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RVPH Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsWhat is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners”A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. Reviva Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.28)($0.28)($0.28)Q2 20241($0.30)($0.30)($0.30)Q3 20241($0.24)($0.24)($0.24)Q4 20241($0.30)($0.30)($0.30)FY 20244($1.12)($1.12)($1.12)Q1 20251($0.33)($0.33)($0.33)Q2 20251($0.31)($0.31)($0.31)Q3 20251($0.24)($0.24)($0.24)Q4 20251($0.21)($0.21)($0.21)FY 20254($1.09)($1.09)($1.09)RVPH Earnings Date and InformationReviva Pharmaceuticals last released its quarterly earnings results on May 14th, 2024. The reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.03. Reviva Pharmaceuticals has generated ($1.59) earnings per share over the last year (($1.59) diluted earnings per share). Earnings for Reviva Pharmaceuticals are expected to grow in the coming year, from ($0.98) to ($0.90) per share. Reviva Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.Read More Reviva Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/12/2024(Estimated)------- 5/14/2024Q1 2024($0.28)($0.25)+$0.03($0.25)--4/15/2024Q4 2023-($0.35)($0.35)($0.35)--11/14/2023Q3 2023($0.35)($0.44)($0.09)($0.44)--8/14/2023Q2 2023($0.29)($0.55)($0.26)($0.55)--5/15/2023Q1 2023($0.36)($0.30)+$0.06($0.30)--3/30/2023Q4 2022($0.23)($0.38)($0.15)($0.38)-- Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022Q3 2022($0.30)($0.18)+$0.12($0.18)--8/15/2022Q2 2022($0.31)($0.29)+$0.02($0.29)--5/16/2022Q1 2022($0.28)($0.40)($0.12)($0.40)--3/15/2022Q4 2021($0.24)($0.24)-($0.26)--11/15/2021Q3 2021($0.23)($0.12)+$0.11($0.12)--8/16/2021Q2 2021($0.24)($0.12)+$0.12($0.12)--5/17/2021Q1 2021-($0.10)($0.10)($0.10)--3/22/2021Q4 2020-($0.84)($0.84)($0.84)--1/14/2021Q3 2021-($0.13)($0.13)($0.13)--10/14/2020Q2 2021-($0.19)($0.19)($0.19)--7/7/2020Q1 2021-($0.09)($0.09)($0.09)--5/4/2020Q4 2020-($0.13)($0.13)($0.13)--1/10/2020Q3 2020-($0.05)($0.05)($0.05)--10/8/2019Q2 2020-($0.02)($0.02)($0.02)--7/3/2019Q1 2020-($0.01)($0.01)($0.01)-- Reviva Pharmaceuticals Earnings - Frequently Asked Questions When is Reviva Pharmaceuticals's earnings date? Reviva Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on RVPH's earnings history. Did Reviva Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Reviva Pharmaceuticals (NASDAQ:RVPH) reported ($0.25) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.28) by $0.03. Learn more on analysts' earnings estimate vs. RVPH's actual earnings. How much profit does Reviva Pharmaceuticals generate each year? Reviva Pharmaceuticals (NASDAQ:RVPH) has a recorded net income of -$39.26 million. RVPH has generated -$1.59 earnings per share over the last four quarters. What is Reviva Pharmaceuticals's EPS forecast for next year? Reviva Pharmaceuticals's earnings are expected to grow from ($0.98) per share to ($0.90) per share in the next year. More Earnings Resources from MarketBeat Related Companies: MRKR Earnings SNSE Earnings LEXX Earnings UNCY Earnings VYNE Earnings JAGX Earnings FBIO Earnings PMN Earnings EYEN Earnings DRRX Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Hormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China? This page (NASDAQ:RVPH) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.